Xilio Therapeutics所有資訊

Xilio Therapeutics | ARS：年度報告

04/26 04:23

Xilio Therapeutics | DEFA14A：其他

04/26 04:16

Xilio Therapeutics | DEF 14A：股東委託書決議

04/26 04:09

Xilio Therapeutics | 424B5：募資說明書

04/15 21:04

Xilio Therapeutics | SC 13G：超過5%持股股東披露文件-Gilead Sciences, Inc.(19.9%)

04/06 04:36

Xilio Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Rock Springs Capital Management LP(8.71%),Rock Springs Capital LLC(8.71%)等

04/06 02:54

Xilio Therapeutics | 4：持股變動聲明-股東 GILEAD SCIENCES, INC.

04/04 06:54

Xilio Therapeutics | 3：首次持股聲明-股東 GILEAD SCIENCES, INC.

04/04 06:54

Xilio Therapeutics | S-8：員工福利計劃證券登記

04/02 04:29

Xilio Therapeutics | 10-K：年度報表

04/02 04:27

Xilio Therapeutics | 8-K：Xilio Therapeutics公佈管道和業務最新情況以及2023年第四季度和全年財務業績

04/02 04:20

Xilio Therapeutics | 8-K：重大事件

03/29 04:17

Xilio Therapeutics | 8-K：重大事件

03/28 19:59

Xilio Therapeutics | SC 13G：超過5%持股股東披露文件-Rock Springs Capital Management LP(5.23%),Rock Springs Capital LLC(5.23%)

02/15 03:19

Xilio Therapeutics | 4：持股變動聲明-股東 Atlas Venture Fund XI, L.P.

02/10 05:36

Xilio Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-OCTAGON CAPITAL ADVISORS LP(0%),OCTAGON INVESTMENTS MASTER FUND LP(0%)等

02/07 05:11

Xilio Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-OCTAGON CAPITAL ADVISORS LP(6.48%),OCTAGON INVESTMENTS MASTER FUND LP(6.48%)等

02/06 05:05

Xilio Therapeutics | 8-K：重大事件

01/19 13:00

Xilio Therapeutics | 4：持股變動聲明-股東 Atlas Venture Fund XI, L.P.

01/16 13:00

Xilio Therapeutics | 4：持股變動聲明-高管 Frankenfield Christopher James

01/03 13:00